Literature DB >> 19166841

Cereblon is expressed in the retina and binds to voltage-gated chloride channels.

Bettina Hohberger1, Ralf Enz.   

Abstract

The function of the central nervous system depends on the correct regulation of ion channels by interacting proteins. Here, we identified cereblon as a new interactor of the voltage-gated chloride channel ClC-2. A distal region of the ClC-2 C-terminus interacts with the Lon domain of cereblon. Cereblon is expressed in several brain regions including the retina. There, we detected cereblon in nuclear and synaptic layers and localized the protein in the same subcellular region of bipolar cell bodies previously reported to express ClC-2. Our data suggest that cereblon might be associated with voltage-gated chloride channels in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19166841     DOI: 10.1016/j.febslet.2009.01.018

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  What is the functional role of the thalidomide binding protein cereblon?

Authors:  Xiu-Bao Chang; A Keith Stewart
Journal:  Int J Biochem Mol Biol       Date:  2011-09-10

2.  A mental retardation-linked nonsense mutation in cereblon is rescued by proteasome inhibition.

Authors:  Guoqiang Xu; Xiaogang Jiang; Samie R Jaffrey
Journal:  J Biol Chem       Date:  2013-08-27       Impact factor: 5.157

Review 3.  Teratogenic effects of thalidomide: molecular mechanisms.

Authors:  Takumi Ito; Hideki Ando; Hiroshi Handa
Journal:  Cell Mol Life Sci       Date:  2011-01-05       Impact factor: 9.261

4.  Cereblon Maintains Synaptic and Cognitive Function by Regulating BK Channel.

Authors:  Tae-Yong Choi; Seung-Hyun Lee; Yoon-Jung Kim; Jae Ryul Bae; Kwang Min Lee; Youhwa Jo; Soo-Jeong Kim; A-Ram Lee; Sekyu Choi; La-Mee Choi; Sunhoe Bang; Mi-Ryoung Song; Jongkyeong Chung; Kyung Jin Lee; Sung Hyun Kim; Chul-Seung Park; Se-Young Choi
Journal:  J Neurosci       Date:  2018-03-12       Impact factor: 6.167

5.  Functional severity of CLCNKB mutations correlates with phenotypes in patients with classic Bartter's syndrome.

Authors:  Chih-Jen Cheng; Yi-Fen Lo; Jen-Chi Chen; Chou-Long Huang; Shih-Hua Lin
Journal:  J Physiol       Date:  2017-06-27       Impact factor: 5.182

6.  Behavioral characterization of cereblon forebrain-specific conditional null mice: a model for human non-syndromic intellectual disability.

Authors:  Anjali M Rajadhyaksha; Stephen Ra; Sarah Kishinevsky; Anni S Lee; Peter Romanienko; Mariel DuBoff; Chingwen Yang; Bojana Zupan; Maureen Byrne; Zeeba R Daruwalla; Willie Mark; Barry E Kosofsky; Miklos Toth; Joseph J Higgins
Journal:  Behav Brain Res       Date:  2011-10-04       Impact factor: 3.332

Review 7.  Protein ubiquitination in lymphoid malignancies.

Authors:  Yibin Yang; Louis M Staudt
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

Review 8.  Cereblon in health and disease.

Authors:  Hyoung Kyu Kim; Tae Hee Ko; Bayalagmaa Nyamaa; Sung Ryul Lee; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Chul-Seung Park; Bernd Nilius; Jin Han
Journal:  Pflugers Arch       Date:  2016-06-24       Impact factor: 3.657

Review 9.  Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma.

Authors:  Xiubao Chang; Yuanxiao Zhu; Changxin Shi; A Keith Stewart
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-12-29       Impact factor: 3.848

10.  Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon.

Authors:  T Van Nguyen; J Eugene Lee; Michael J Sweredoski; Seung-Joo Yang; Seung-Je Jeon; Joseph S Harrison; Jung-Hyuk Yim; Sang Ghil Lee; Hiroshi Handa; Brian Kuhlman; Ji-Seon Jeong; Justin M Reitsma; Chul-Seung Park; Sonja Hess; Raymond J Deshaies
Journal:  Mol Cell       Date:  2016-03-17       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.